Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028188
Filing Date
2021-05-17
Accepted
2021-05-17 08:00:39
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20210331.htm   iXBRL 10-Q 1764316
2 EX-10.1 scyx-ex101_86.htm EX-10.1 478955
3 EX-10.2 scyx-ex102_87.htm EX-10.2 199485
4 EX-31.1 scyx-ex311_12.htm EX-31.1 18619
5 EX-31.2 scyx-ex312_11.htm EX-31.2 20079
6 EX-32.1 scyx-ex321_8.htm EX-32.1 9411
  Complete submission text file 0001564590-21-028188.txt   9071618

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA scyx-20210331.xsd EX-101.SCH 53087
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20210331_cal.xml EX-101.CAL 48661
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20210331_def.xml EX-101.DEF 180714
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20210331_lab.xml EX-101.LAB 448420
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20210331_pre.xml EX-101.PRE 346692
12 EXTRACTED XBRL INSTANCE DOCUMENT scyx-10q_20210331_htm.xml XML 1853609
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 21927651
SIC: 2834 Pharmaceutical Preparations